Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Lorgis · SciRah

Researcher profile · Semantic Scholar

V. Lorgis

Share profile

V. Lorgis — researcher profile on SciRah

h-index: 19
Works: 51
Citations: 1,558

Most-cited papers

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
E. Gobbini, M. Ezzalfani, V. Diéras, T. Bachelot +24 more
2018European Journal of Cancer270 citations
Semantic Scholar
The molecular landscape of glioma in patients with Neurofibromatosis 1
F. D'Angelo, M. Ceccarelli, Tala, L. Garofano +43 more
2018Nature Medicine185 citations Open access
Semantic Scholar
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
É. Deluche, A. Antoine, T. Bachelot, A. Lardy-Cléaud +23 more
2020European Journal of Cancer176 citations
Semantic Scholar
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
É. Le Rhun, J. Wallet, A. Mailliez, M. le Deley +7 more
2019Neuro-Oncology94 citations Open access
Semantic Scholar
Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.
V. Lorgis, M. Algros, C. Villanueva, L. Chaigneau +9 more
2011Breast77 citations Open access
Semantic Scholar
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.
S. Delaloge, D. Pérol, C. Courtinard, E. Brain +22 more
2016Annals of Oncology68 citations Open access
Semantic Scholar
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
O. Humbert, J. Riedinger, C. Charon-Barra, A. Berriolo-Riedinger +7 more
2015Clinical Cancer Research62 citations
Semantic Scholar
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
Jean-Florian Guion-Dusserre, V. Lorgis, J. Vincent, L. Bengrine +1 more
2015World Journal of Gastroenterology61 citations Open access
Semantic Scholar
Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma.
Amélie Darlix, C. Baumann, V. Lorgis, F. Ghiringhelli +7 more
2013Anticancer Research55 citations
Semantic Scholar
Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
M. Preusser, A. Silvani, É. Le Rhun, R. Soffietti +34 more
2021Neuro-Oncology54 citations Open access
Semantic Scholar
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts
V. Lorgis, Géric Maura, G. Coppa, K. Hassani +5 more
2012Journal of Neuro-Oncology53 citations
Semantic Scholar
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
T. Aparicio, M. Ducreux, R. Faroux, E. Barbier +305 more
2018European Journal of Cancer41 citations Open access
Semantic Scholar
Hepatic Arterial Infusion of Gemcitabine plus Oxaliplatin as Second-Line Treatment for Locally Advanced Intrahepatic Cholangiocarcinoma: Preliminary Experience
F. Ghiringhelli, V. Lorgis, J. Vincent, S. Ladoire +1 more
2014Chemotherapy36 citations
Semantic Scholar
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
E. Guardiola, D. Delroeux, B. Heyd, Marielle Combe +6 more
2009World Journal of Surgical Oncology36 citations Open access
Semantic Scholar
Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients.
L. Rambach, A. Bertaut, J. Vincent, V. Lorgis +2 more
2014World Journal of Gastroenterology32 citations Open access
Semantic Scholar
Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
F. Ghiringhelli, D. Bichard, S. Limat, V. Lorgis +11 more
2014Annals of Surgical Oncology26 citations Open access
Semantic Scholar
Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
M. Preusser, A. Silvani, É. Le Rhun, R. Soffietti +15 more
2019Journal of Clinical Oncology22 citations
Semantic Scholar
Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study.
V. Lorgis, B. Chauffert, J. Gentil, F. Ghiringhelli
2012Anticancer Research21 citations
Semantic Scholar
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
J. Hadoux, P. Afchain, T. Walter, D. Tougeron +8 more
2021Digestive and Liver Disease19 citations Open access
Semantic Scholar
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
O. Le Saux, A. Lardy-Cléaud, S. Frank, M. Debled +20 more
2019European Journal of Cancer18 citations Open access
Semantic Scholar
FOLFIRINOX Bevacizumab Is a Promising Therapy for Chemorefractory Metastatic Colorectal Cancer
M. Chaix, J. Vincent, V. Lorgis, F. Ghiringhelli
2014Oncology18 citations
Semantic Scholar
Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
P. Barthélémy, Y. Loriot, E. Voog, J. Eymard +16 more
2023Journal of Clinical Oncology17 citations
Semantic Scholar
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study
M. Morisse, N. Etienne-Selloum, D. Bello-Roufai, M. Blonski +7 more
2019Journal of Neuro-Oncology14 citations
Semantic Scholar
Complementary and alternative medicine use in glioma patients in France
É. Le Rhun, P. Devos, V. Bourg, A. Darlix +11 more
2019Journal of Neuro-Oncology13 citations Open access
Semantic Scholar
Individualized Prediction of Menses Recovery After Chemotherapy for Early‐stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials
B. Pistilli, C. Mazouni, A. Zingarello, M. Faron +15 more
2019Clinical Breast Cancer13 citations Open access
Semantic Scholar
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
A. Vasseur, L. Cabel, O. Trédan, M. Chevrier +16 more
2019Angiogenesis12 citations
Semantic Scholar
Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymoma.
V. Lorgis, O. Varbédian, F. Ghiringhelli
2012Anticancer Research11 citations
Semantic Scholar
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
M. Annonay, L. Gauquelin, R. Geiss, M. Ung +22 more
2021Breast10 citations Open access
Semantic Scholar
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis
C. Jankowski, S. Guiu, Marion Cortet, C. Charon-Barra +8 more
2016Breast Cancer Research and Treatment7 citations
Semantic Scholar
Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
Celina Bihan, S. Foscolo, M. Boone, M. Blonski +7 more
2012Case Reports in Oncology7 citations Open access
Semantic Scholar
[Non-metastatic triple-negative breast cancer in 2016: Definitions and management].
H. Portha, C. Jankowski, Marion Cortet, I. Desmoulins +4 more
2016Gynécologie Obstétrique & Fertilité6 citations
Semantic Scholar
[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].
J. Riedinger, V. Goussot, I. Desmoulins, V. Lorgis +4 more
2016Bulletin du Cancer6 citations
Semantic Scholar
Abstract 3390: Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
J. Pierga, A. Silveira, E. Girard, V. Lorgis +18 more
2020Cancer Chemistry5 citations
Semantic Scholar
Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study.
S. Delaloge, D. Pérol, E. Brain, B. Asselain +16 more
20164 citations
Semantic Scholar
Multimodality liquid biopsy for early monitoring and outcome prediction in first-line metastatic HER2-negative breast cancer: Final results of the prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG)— COMET study.
J. Pierga, A. Silveira, O. Trédan, M. Tanguy +14 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Anticancer therapy in patients with porphyrias: evidence today
A. Thiery-Vuillemin, L. Chaigneau, N. Méaux-Ruault, C. Villanueva +6 more
2008Expert Opinion on Drug Safety3 citations
Semantic Scholar
[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].
Stéphane Konan, V. Goussot, I. Desmoulins, V. Lorgis +6 more
2015Bulletin du Cancer2 citations
Semantic Scholar
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
M. Réda, P. Macaire, H. Bellio, L. Uwer +12 more
2022Cancer Chemotherapy and Pharmacology1 citations
Semantic Scholar
1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)
P. Barthélémy, C. Thibault, E. Voog, J. Eymard +15 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
1707P A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin
A. Schmitt, M. Réda, P. Macaire, H. Bellio +12 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers
J. Legoux, R. Faroux, N. Barrière, K. Le Malicot +12 more
20201 citations Open access
Semantic Scholar
OS10.4 Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for leptomeningeal metastasis from breast cancer - a randomized study. Final results
É. Le Rhun, J. Wallet, A. Mailliez, M. le Deley +7 more
2019Neuro-Oncology1 citations Open access
Semantic Scholar
Assessment of multiple endocrine therapies for metastatic breast cancer in a multicenter national observational study.
O. Le Saux, Audrey Lardy-Cleaud, S. Frank, P. Cottu +16 more
20171 citations
Semantic Scholar
326P National multicentre retrospective study on metastatic breast cancer patients to characterize long responder under eribulin: LORELINE study
Mouret Reynier, M. Paillard, L. Uwer, I. Molnar +10 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
147P When a single G-CSF administration is better than longer duration: Example in patients treated by eribulin
A. Schmitt, M. Réda, P. Macaire, H. Bellio +12 more
20210 citations Open access
Semantic Scholar
Abstract P1-19-19: Treatments and outcome in older versus younger women with HER2-positive metastatic breast cancer in the multicenter national observational ESME database
M. Annonay, M. Abiven, E. Brain, M. Ung +20 more
20200 citations
Semantic Scholar
Abstract PD7-06: MAAT: Menses after adjuvant treatment. Prediction of menses recovery after chemotherapy for early breast cancer (BC) by using a nomogram model in UNICANCER PACS04 and PACS05 trials
B. Pistilli, C. Mazouni, A. Zingarello, M. Faron +15 more
20180 citations
Semantic Scholar
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].
S. Ladoire, V. Derangère, L. Arnould, M. Thibaudin +6 more
2017Annales de Pathologie0 citations
Semantic Scholar
Les gliomes de l’adulte
V. Lorgis
20150 citations
Semantic Scholar
[Preoperative treatments of rectal cancers].
J. Bosset, F. Nguyen, M. Bosset, S. Servagi-Vernat +2 more
2007Cancer Radiothérapie0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Uwer×12
Invite
L. Uwer — researcher profile on SciRah
A. Gonçalves×11
Invite
A. Gonçalves — researcher profile on SciRah
F. Ghiringhelli×11
Invite
F. Ghiringhelli — researcher profile on SciRah
T. Bachelot×9
Invite
T. Bachelot — researcher profile on SciRah

×9

Invite

M. Debled — researcher profile on SciRah

M. Mouret-Reynier×9

Invite

M. Mouret-Reynier — researcher profile on SciRah

I. Desmoulins×9

Invite

I. Desmoulins — researcher profile on SciRah

Invite

J. Ferrero — researcher profile on SciRah

Invite

C. Lévy — researcher profile on SciRah

C. Jouannaud×8

Invite

C. Jouannaud — researcher profile on SciRah

Invite

S. Delaloge — researcher profile on SciRah

Invite

P. Fumoleau — researcher profile on SciRah